PTC Therapeutics (United States)
In research, PTC Therapeutics (United States) stands highest in Life Sciences (#11,480 of 14,347 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology — Biochemistry, Genetics and Molecular Biology is 8.0× its share of world research.
- World rank, 2022–2025
- #20,085 of 28,054 · #28,263 all time
- Rank in United States
- #2,927 of 4,192
- Research works
- 204 ▲ 32% vs 2013–17
- Citations
- 4.8k 23.6 per fractional work
- Top-10% rate
- 6.8% record average 16.5%
- Open access
- 41% world 28%
What is PTC Therapeutics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #11,480 of 14,347 | 11.3% | 120 |
Each strip is that field’s whole ranked pool, with the notch where PTC Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does PTC Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 8.0× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 27.2 works8.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 14.7×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 14.7×
- Biochemistry, Genetics and Molecular Biology 8.0×
- Neuroscience 7.9×
- Veterinary 4.6×
- Medicine 1.6×
- Chemistry 1.1×
- Immunology and Microbiology 0.9×
- Materials Science 0.3×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Business, Management and Accounting 0.1×
- Computer Science 0.0×
- Psychology 0.0×
Who are the top researchers at PTC Therapeutics (United States)?
Ranked on the composite score, Stuart W. Peltz, Gary Elfring and Marla Weetall lead among researchers whose main affiliation is PTC Therapeutics (United States).
- 1 Stuart W. Peltz United States · #294,127 worldwide 167 citations · 25 works
- 2 Gary Elfring United States · #295,448 worldwide 88 citations · 25 works
- 3 Marla Weetall United States · #657,317 worldwide 29 citations · 19 works
- 4 A. Reha United States · #702,473 worldwide 44 citations · 15 works
- 5 Robert J. Spiegel United States · #728,065 worldwide 38 citations · 17 works
- 6 Thomas W. Davis United States · #774,390 worldwide 63 citations · 17 works
- 7 Christian Werner United States · #1,012,782 worldwide 51 citations · 31 works
- 8 Rongrong Zhang United States · #1,079,498 worldwide 33 citations · 30 works
- 9 Ellen Welch United States · #1,345,828 worldwide 13 citations · 17 works
Which keywords describe research at PTC Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Mitochondrial Dysfunction, Metabolic Disorders, Newborn Screening, Chaperones, Huntington's Disease, Protein Aggregation, Mitochondrial Function and Biochemical Genetics.
- Genetic Variation
- Clinical Management
- Nucleotide Metabolism
- Mitochondrial Fission
- Neurodegeneration
- Cell Death
- Genetics
- Aging
- Metabolic Regulation
- Skeletal Muscle Atrophy
- Stem Cells
- Ketogenic Diet
- Reactive Oxygen Species
- Cancer Therapy
- Metabolic Syndrome
- Oxidative Stress
- Biochemical Genetics
- Protein Aggregation
- Chaperones
- Metabolic Disorders
- Mitochondrial Dysfunction
- Newborn Screening
- Huntington's Disease
- Mitochondrial Function
- Carnitine
- Inflammation
- Neurological Disorders
- Neurodegenerative Diseases
- Cancer
- Low-Carbohydrate Diet
- Muscle Regeneration
- Antioxidant
- Mitochondria
- Genetic Variants
- Genetic Mutations
- Enzyme Regulation
- Pharmacology
- Mitochondrial Fusion
- Purine Biosynthesis
- Gene Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Mitochondrial Dysfunction11▲ 60×8 topics
- Metabolic Disorders8▲ 108×3 topics
- Newborn Screening8▲ 228×2 topics
- Chaperones7▲ 196×2 topics
- Huntington's Disease7▲ 370×1 topic
- Protein Aggregation7▲ 210×1 topic
- Mitochondrial Function7▲ 116×3 topics
- Biochemical Genetics7▲ 306×1 topic
- Carnitine7▲ 306×1 topic
- Oxidative Stress6▲ 5.5×14 topics
- Inflammation5▲ 4.0×12 topics
- Metabolic Syndrome4▲ 7.1×4 topics
- Neurological Disorders4▲ 9.5×5 topics
- Cancer Therapy3▲ 8.8×4 topics
- Neurodegenerative Diseases3▲ 29×3 topics
- Reactive Oxygen Species3▲ 12×4 topics
- Cancer3▲ 3.5×10 topics
- Ketogenic Diet3▲ 48×1 topic
- Low-Carbohydrate Diet3▲ 54×1 topic
- Stem Cells3▲ 17×2 topics
- Muscle Regeneration3▲ 159×1 topic
- Skeletal Muscle Atrophy3▲ 159×1 topic
- Antioxidant3▲ 6.0×5 topics
- Metabolic Regulation2▲ 24×3 topics
- Mitochondria2▲ 28×2 topics
- Aging2▲ 6.1×4 topics
- Genetic Variants2▲ 19×3 topics
- Genetics2▲ 4.8×5 topics
- Genetic Mutations2▲ 7.0×9 topics
- Cell Death2▲ 13×3 topics
- Enzyme Regulation2▲ 118×2 topics
- Neurodegeneration2▲ 9.7×4 topics
- Pharmacology2▲ 12×3 topics
- Mitochondrial Fission2▲ 50×1 topic
- Mitochondrial Fusion2▲ 50×1 topic
- Nucleotide Metabolism2▲ 166×1 topic
- Purine Biosynthesis2▲ 166×1 topic
- Clinical Management2▲ 14×2 topics
- Gene Therapy2▲ 14×3 topics
- Genetic Variation2▲ 12×2 topics
Which research topics does PTC Therapeutics (United States) publish most on?
By volume in 2022–2025: Genetic Neurodegenerative Diseases, Metabolism and Genetic Disorders, Diet and metabolism studies and Muscle Physiology and Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 7 works
- 2 Metabolism and Genetic Disorders Clinical Biochemistry 7 works
- 3 Diet and metabolism studies Physiology 3 works
- 4 Muscle Physiology and Disorders Molecular Biology 3 works
- 5 Mitochondrial Function and Pathology Molecular Biology 2 works
- 6 Biochemical and Molecular Research Molecular Biology 2 works
- 7 Pharmacogenetics and Drug Metabolism Pharmacology 2 works
- 8 Neurogenetic and Muscular Disorders Research Genetics 1 works
- 9 Coenzyme Q10 studies and effects Molecular Biology 1 works
- 10 Amino Acid Enzymes and Metabolism Biochemistry 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has PTC Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 32% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South Plainfield
- Applied Optronics (United States)
- Prolong Pharmaceuticals (United States)
- Kobo Products (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.